US 8389515
2,4-pyrimidinediamine compounds and prodrugs and their uses
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8389515 (2,4-pyrimidinediamine compounds and prodrugs and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P13/12